GRANULES INDIA
|
The Current P/E Ratio of GRANULES INDIA is 29.22.
Share Price | ₹593.3 | Oct 17,2024 |
Market Cap | ₹14,380.4 Cr | |
Earnings-TTM | ₹492.1 Cr | TTM-Consolidated Results |
Price/Earnings | 29.22x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GRANULES INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹14,380.4 Cr] as on Oct 17,2024
(/) Earnings [ ₹492.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 29.22x ]
Thus, for GRANULES INDIA , the investors are currently willing to pay 29.22 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GRANULES INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GRANULES INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of GRANULES INDIA
PE Ratio Performance Analysis for GRANULES INDIA
- GRANULES INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 16.46x.
- GRANULES INDIA 's operated at median p/e ratio of 13.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GRANULES INDIA 's p/e ratio peaked in Mar2024 at 25.71x.
- GRANULES INDIA 's p/e ratio hit its five-year low in Mar2020 of 10.89x.
How does GRANULES INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GRANULES INDIA | 492.06 | 29.22 | 14,380.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,506.70 | 43.16 | 453,486.0 |
CIPLA LTD | 4,335.02 | 29.03 | 125,852.0 |
DR REDDYS LABORATORIES LTD | 5,549.00 | 20.15 | 111,799.0 |
ZYDUS LIFESCIENCES LTD | 4,181.90 | 24.56 | 102,726.0 |
DIVIS LABORATORIES LTD | 1,674.00 | 96.37 | 161,321.0 |
MANKIND PHARMA LTD | 1,976.25 | 54.38 | 107,467.0 |
TORRENT PHARMACEUTICALS LTD | 1,735.00 | 66.25 | 114,943.0 |
LUPIN LTD | 2,287.78 | 43.41 | 99,304.7 |
AUROBINDO PHARMA LTD | 3,533.22 | 24.13 | 85,273.3 |
ABBOTT INDIA LTD | 1,238.99 | 48.74 | 60,382.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GRANULES INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.15x |
Max industry PE | 96.37x |
Median industry PE | 43.16x |
Average industry PE | 43.58x |
You may also like the below Video Courses